Categories: News

Playtika Announces Date of Fourth Quarter 2020 Results Conference Call

HERZLIYA, Israel, Jan. 28, 2021 (GLOBE NEWSWIRE) — Playtika Holding Corp. (NASDAQ:PLTK) announced today it will release financial results for the fourth quarter 2020 before U.S. markets open on Thursday, February 25, 2021.

On the same day, Playtika management will hold a conference call to discuss the results at 5:30 a.m. Pacific Time, 8:30 a.m. Eastern Time.

A live webcast of the conference call and earnings release materials can be found on Playtika’s Investor Relations website at investors.playtika.com. To listen live, participants may register here, or dial into the conference call at (833) 957-2623 or (661) 407-1623 for international callers. Please use conference ID: 1443938

About Playtika
Playtika Holding Corp. is a leading mobile gaming company and monetization platform with over 35 million monthly active users across a portfolio of games titles. Founded in 2010, Playtika was among the first to offer free-to-play social games on social networks and, shortly after, on mobile platforms. Headquartered in Herzliya, Israel, and guided by a mission to entertain the world through infinite ways to play, Playtika has over 3,700 employees in 19 offices worldwide including Tel-Aviv, London, Berlin, Vienna, Helsinki, Montreal, Chicago, Las Vegas, Santa Monica, Newport Beach, Sydney, Kiev, Bucharest, Minsk, Dnepr, and Vinnytsia.

Contact

Investor Contact
Playtika
David Niederman
davidni@playtika.com

Press Contact
The OutCast Agency
Angela Allison
playtika@theoutcastagency.com

Staff

Recent Posts

Global Microscopy Market to Reach USD 10.6 Billion by 2029 driven by Healthcare Innovations | MarketsandMarkets™

CHICAGO, July 4, 2024 /PRNewswire/ -- The global microscopy market is poised for significant growth, expected…

3 hours ago

FSD Pharma Files Amended and Restated Material Change Report

Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…

6 hours ago

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL)…

6 hours ago

ICPO Foundation partners with Nuclear Medicine Research Infrastructure (NuMeRI) to establish an ICPO Collaborating Center

ICPO Center NuMeRI ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to…

6 hours ago

Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

6 hours ago